Darifenacin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

27 Suppliers, 15 USDMF, 9 EU WC, 7 NDC API, 16 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

8 Suppliers

8 Suppliers

DOSSIERs // Finished Dosage Forms

55 Dossiers, 20 FDA Orange Book, 14 Europe, 6 Canada, 5 South Africa, 10 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 31 Kerry, 10 Microlex e.U, 10 Sigachi Industries, 10 Corel Pharma Chem, 9 Roquette, 9 BASF, 8 Gangwal Chemicals, 8 Gangwal Healthcare, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Seppic, 5 Nanjing Well Pharmaceutical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 3 Clariant, 3 Actylis, 3 Kima Chemical, 3 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 2 Vasa Pharmachem, 2 Nomisma Healthcare, 2 The Dow Chemical Company, 2 Novo Excipients, 2 Prachin Chemical, 2 Seqens, 2 Pluviaendo, 1 Avesta Pharma, 1 Ulanqab Kema New Material, 1 ACG Worldwide, 1 Qualicaps, 1 Pharmatrans-Sanaq, 1 SPI Pharma, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Finar

EXCIPIENTS BY APPLICATIONS

50 Coating Systems & Additives, 48 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 20 Direct Compression, 18 Thickeners and Stabilizers, 17 Lubricants & Glidants, 14 Topical, 13 Co-Processed Excipients, 11 Film Formers & Plasticizers, 11 Granulation, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 7 Solubilizers, 6 API Stability Enhancers, 5 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

10 Finished Drug Prices

10 Finished Drug Prices

MARKET PLACE

2 APIs, 4 DOSSIERS // FDF

PATENTS

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 BioAnalytical Methods, 3 USP, 4 Others

DIGITAL CONTENT

12 News

12 News

Annual Sales of Darifenacin reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Darifenacin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

27 Suppliers

15 USDMF

9 EU WC

7 NDC API

16 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

8 Suppliers

DOSSIERs // Finished Dosage Forms

55 Dossiers

20 FDA Orange Book

14 Europe

6 Canada

5 South Africa

10 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

31 Kerry

10 Microlex e.U

10 Sigachi Industries

10 Corel Pharma Chem

9 Roquette

9 BASF

8 Gangwal Chemicals

8 Gangwal Healthcare

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 Seppic

5 Nanjing Well Pharmaceutical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 DFE Pharma

3 Clariant

3 Actylis

3 Kima Chemical

3 DKSH

3 Boai NKY Pharmaceuticals Ltd

2 Vasa Pharmachem

2 Nomisma Healthcare

2 The Dow Chemical Company

2 Novo Excipients

2 Prachin Chemical

2 Seqens

2 Pluviaendo

1 Avesta Pharma

1 Ulanqab Kema New Material

1 ACG Worldwide

1 Qualicaps

1 Pharmatrans-Sanaq

1 SPI Pharma

1 Aeon Procare

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Finar

EXCIPIENTS BY APPLICATIONS

50 Coating Systems & Additives

48 Fillers, Diluents & Binders

28 Controlled & Modified Release

20 Direct Compression

18 Thickeners and Stabilizers

17 Lubricants & Glidants

14 Topical

13 Co-Processed Excipients

11 Film Formers & Plasticizers

11 Granulation

7 Parenteral

7 Disintegrants & Superdisintegrants

7 Solubilizers

6 API Stability Enhancers

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons